Correlation Between Apogee Therapeutics, and Chicago Atlantic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Chicago Atlantic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Chicago Atlantic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apogee Therapeutics, Common and Chicago Atlantic BDC,, you can compare the effects of market volatilities on Apogee Therapeutics, and Chicago Atlantic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Chicago Atlantic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Chicago Atlantic.

Diversification Opportunities for Apogee Therapeutics, and Chicago Atlantic

-0.05
  Correlation Coefficient

Good diversification

The 3 months correlation between Apogee and Chicago is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Chicago Atlantic BDC, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chicago Atlantic BDC, and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Chicago Atlantic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chicago Atlantic BDC, has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Chicago Atlantic go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and Chicago Atlantic

Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to under-perform the Chicago Atlantic. In addition to that, Apogee Therapeutics, is 2.15 times more volatile than Chicago Atlantic BDC,. It trades about -0.04 of its total potential returns per unit of risk. Chicago Atlantic BDC, is currently generating about -0.05 per unit of volatility. If you would invest  1,235  in Chicago Atlantic BDC, on December 20, 2024 and sell it today you would lose (84.00) from holding Chicago Atlantic BDC, or give up 6.8% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Apogee Therapeutics, Common  vs.  Chicago Atlantic BDC,

 Performance 
       Timeline  
Apogee Therapeutics, 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Chicago Atlantic BDC, 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Chicago Atlantic BDC, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Chicago Atlantic is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Apogee Therapeutics, and Chicago Atlantic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Apogee Therapeutics, and Chicago Atlantic

The main advantage of trading using opposite Apogee Therapeutics, and Chicago Atlantic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Chicago Atlantic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chicago Atlantic will offset losses from the drop in Chicago Atlantic's long position.
The idea behind Apogee Therapeutics, Common and Chicago Atlantic BDC, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators